首页> Nature communications> SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.

导出 OA

翻译打印收藏纠错

第一作者： Ann-Sofie,Rudberg

第一单位： Department of Neurology, Danderyd hospital, Stockholm, Sweden.;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

作者： Ann-Sofie,Rudberg ^[1] ; Sebastian,Havervall ^[2] ; Anna,Månberg ^[3] ; August,Jernbom Falk ^[3] ; Katherina,Aguilera ^[2] ; Henry,Ng ^[4] ; Lena,Gabrielsson ^[2] ; Ann-Christin,Salomonsson ^[2] ; Leo,Hanke ^[5] ; Ben,Murrell ^[5] ; Gerald,McInerney ^[5] ; Jennie,Olofsson ^[3] ; Eni,Andersson ^[3] ; Cecilia,Hellström ^[3] ; Shaghayegh,Bayati ^[3] ; Sofia,Bergström ^[3] ; Elisa,Pin ^[3] ; Ronald,Sjöberg ^[3] ; Hanna,Tegel ^[6] ; My,Hedhammar ^[6] ; Mia,Phillipson ^[4] ; Peter,Nilsson ^[3] ; Sophia,Hober ^[6] ; Charlotte,Thålin ^[7]

作者单位： Department of Neurology, Danderyd hospital, Stockholm, Sweden.;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. ^[1] Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden. ^[2] Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. ^[3] Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden. ^[4] Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. ^[5] Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden. ^[6] Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden. charlotte.thalin@sll.se. ^[7]